Article
Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population.
The American journal of drug and alcohol abuse - 4 Jul 2022
Kramer Jennifer R, Puenpatom Amy, Cao Yumei, Yu Xian, El-Serag Hashem B, Kanwal Fasiha
Abstract excerpt
Background: Hepatitis C virus (HCV) infections in the United States have increased in recent years, with the most rapid rise among people who inject drugs (PWIDs). Historically, there have been concerns regarding treatment adherence among PWIDs with HCV infection, leading to undertreatment of this population and increased HCV transmission. Elbasvir (EBR)/grazoprevir (GZR) has demonstrated high rates of virologic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.